Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases
TechCrunch
DECEMBER 2, 2020
Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis.
Let's personalize your content